OraSure Technologies Inc (FRA:EP3)
€ 3.62 0 (0%) Market Cap: 275.92 Mil Enterprise Value: 22.24 Mil PE Ratio: 25.33 PB Ratio: 0.67 GF Score: 70/100

OraSure Technologies Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 23, 2021 / 03:20PM GMT
Release Date Price: €8.09 (+6.14%)
Andrew Cooper
Raymond James - Analyst

Good morning, everyone, and welcome to the -- day three of the Raymond James Human Health Innovation Conference. Thanks for joining us. For those who don't know, I'm Andrew Cooper. I cover diagnostics here for Raymond James, and we are excited to have OraSure joining us this morning. (Conference Instructions)

But with that said -- like I said, we're happy to have CEO, Dr. Steve Tang; CFO, Roberto Cuca; as well as Scott Gleason with us today from IR. There's a lot of specifics I'm going to want to dive into. But maybe first just to start us off, Steve, Roberto, could you give us the high-level overview for folks that are a little newer to the story, and a little bit of the latest and greatest on where we sit today?

Steve Tang
OraSure Technologies, Inc. - President and CEO

Happy to do so, Andrew. First, thank you, we really appreciate your invitation to attend the Raymond James Human Health Innovation Conference and present today. As a company, OraSure is highly focused on enhancing health and well-being through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot